Cyclic adenosine monophosphate induces plasminogen activator inhibitor-1 expression in human mast cells

Biochemical and Biophysical Research Communications

Volumn 400, Issue 4, 2010, Pages 569-574

  Ma, Zhongcai ^a   Kwong, Kenny Y C ^a   Tovar, Jason P ^a   Paek, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclic adenosine monophosphate (cAMP); Hypoxia response element (HRE); IgE receptor cross linking; Ionomycin; Mast cell (MC); Plasminogen activator inhibitor 1 (PAI 1)

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN E RECEPTOR; IONOMYCIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; ASTHMA; EFFECTOR CELL; HUMAN; HUMAN CELL; HYPOXIA; MAST CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION;

ASTHMA; CALCIUM; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION; HUMANS; MAST CELLS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; RECEPTORS, IGE; RESPONSE ELEMENTS;

EID: 77957258011     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.105     Document Type: Article

References (28)

1. Ma Z., Paek D., Oh C.K. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation. Clin. Exp. Allergy 2009, 39:1136-1144.
2. Bradding P., Walls A.F., Holgate S.T. The role of the mast cells in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006, 117:1277-1284.
3. Cho S.H., Tam S.W., Demissie-Sanders S., Filler S.A., Oh C.K. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J. Immunol. 2000, 165:3154-3161.
4. Nakajima T., Inagaki N., Tanaka H., Tanaka A., Yoshikawa M., Tamari M., Hasegawa K., Matsumoto K., Tachimoto H., Ebisawa M., Tsujimoto G., Matsuda H.H., Nagai H., Saito H. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following FcE{open} receptor I cross-linking: an interspecies comparison. Blood 2002, 100:3861-3868.
5. Kucharewicz I., Mogielnicki A., Kasacka I., Buczko W., Bodzenta-Łukaszyk A. Plasmin system regulation in an ovalbumin-induced rat model of asthma. Int. Arch. Allergy Immunol. 2008, 147:190-196.
6. Weston M.C., Peachell P.T. Regulation of human mast cell and basophil function by Camp. Gen. Pharmac. 1998, 31:715-719.
7. Peachell P. Regulation of mast cells by β-agonists. Clin. Rev. Allergy Immunol. 2006, 31:131-142.
8. Ma Z., Jhun B., Jung S.Y., Oh C.K. Binding of upstream stimulatory factor 1 to the E-Box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells. J. Allergy Clin. Immunol. 2008, 121:1006-1012.
9. Kirshenbaum A.S., Akin C., Wu Y., Rottem M., Goff J.P., Beaven M.A., Rao K., Metcalfe D.D. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia: activation following aggregation of FcE{open}RI or FcγRI. Leuk. Res. 2003, 27:677-682.
10. Ma Z., Jhun B., Oh C.K. Upstream stimulating factor-1 mediates the E-box-dependent transcriptional repression of the plasminogen activator inhibitor-1 gene in human mast cells. FEBS Lett. 2007, 581:4485-4490.
11. Cui T.X., Kwok R., Schwartz J. Cooperative regulation of endogenous cAMP-response element binding protein and CCAAT/enhancer-binding protein β in GH-stimulated c-fos expression. J. Endocrinol. 2008, 196:89-100.
12. Ahn S., Olive M., Aggarwal S., Krylov D., Ginty D.D., Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol. Cell Biol. 1998, 18:967-977.
13. Kapatos G., Vunnava P., Wu Y. Protein kinase A-dependent recruitment of RNA polymerase II, C/EBPβ and NF-Y to the rat GTP cyclohydrolase I proximal promoter occurs without alterations in histone acetylation. J. Neurochem. 2007, 101:1119-1133.
14. Kvietikova I., Wenger R.H., Marti H.H., Gassmann M. The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 1997, 51:564-566.
15. Dimova E.Y., Jakubowska M.M., Kietzmann T.K. CREB binding to the hypoxia-inducible factor-I responsive elements in the plasminogen activator inhibitor-1 promoter mediates the glucagon effect. Thromb. Haemost. 2007, 98:296-303.
16. Gottschling-Zeller H., Aprath I., Skurk T., Hauner H. β-Adrenoceptor agonists and other cAMP elevating agents suppress PAI-1 production of human adipocytes in primary culture. Horm. Metab. Res. 2000, 32:509-514.
17. B. del Valle-Perez, O.M. Martinez-Estrada, S. Vilaro, F. Ventura, F. Vinals, cAMP inhibits TGF β1-induced in vitro angiogenesis, FEBS Lett. 569 (2004) 105-111.
18. R.B. Francis Jr., S. Neely, Inhibition of endothelial secretion of tissue-type plasminogen activator and its rapid inhibitor by agents which increase intracellular cyclic AMP, Biochim. Biophys. Acta 1012 (1989) 207-213.
19. Lau H.K., Ho J. Regulation of plasminogen activator inhibitor-1 secretion by growth factors in smooth muscle cells. Blood Coagul. Fibrinolysis 2002, 13:541-549.
20. Liang M.H., Wendland D.M.Chuang Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling. Mol. Cell Neurosci. 2008, 37:440-453.
21. Imagawa S., Fujii S., Dong J., Furumoto T., Kaneko T., Zaman T., Satoh Y., Tsutsui H., Sobel B.E. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2407-2413.
22. Cha-Molstad H., Keller D.M., Yochum G.S., Impey S., Goodman R.H. Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. Proc. Natl. Acad. Sci. USA 2004, 101:13572-13577.
23. L.R. Landa Jr., M. Harbeck, K. Kaihara, O. Chepurny, K. Kitiphongspattana, O. Graf, V.O. Nikolaev, M.J. Lohse, G.G. Holz, M.W. Roe, Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 β-cell line, J. Biol. Chem. 280 (2005) 31294-31302.
24. 2+/calmodulin-dependent and cAMP-dependent kinases in induction of c-fos in human mesangial cells. Am. J. Physiol. Renal. Physiol. 2002, 283:F888-F894.
25. Sugiura T., Imai E., Moriyama T., Horio M., Hori M. Calcium channel blockers inhibit proliferation and matrix production in rat mesangial cells: possible mechanisms of suppression of AP-1 and CREB activities. Nephron 2000, 85:71-80.
26. Cockcroft D.W. Clinical concerns with inhaled β2-agonists: adult asthma. Clin. Rev. Allergy Immunol. 2006, 31:197-208.
27. Wagers S.S., Norton R.J., Rinaldi L.M., Bates J.H., Sobel B.E., Irvin C.G. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J. Clin. Invest. 2004, 114:104-111.
28. Kuramoto E., Nishiuma T., Kobayashi K., Yamamoto M., Kono Y., Funada Y., Kotani Y., Sisson T.H., Simon R.H., Nishimura Y. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296:L337-L346.